Giancarlo Troncone
Overview
Explore the profile of Giancarlo Troncone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
319
Citations
4416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malapelle U, Chen C, de Alava E, Hofman P, Kazdal D, Kim T, et al.
J Pathol Clin Res
. 2025 Mar;
11(2):e70018.
PMID: 40052485
Current European/US guidelines recommend that molecular testing in advanced non-small cell lung cancer (aNSCLC) be performed using next-generation sequencing (NGS). However, the global uptake of NGS is limited, largely owing...
2.
Marchetti C, Ergasti R, Capomacchia F, Giannarelli D, Mastrantoni L, Pepe F, et al.
Gynecol Oncol
. 2025 Mar;
195:16-25.
PMID: 40048982
Objective: Selecting the maintenance strategy for advanced tubo-ovarian high-grade serous carcinoma (HGSC) is challenging. This study evaluates the correlation among chemotherapy response score (CRS), homologous recombination deficiency (HRD) status, and...
3.
De Luca C, Russo G, Nacchio M, Ingenito M, Palumbo L, Gragnano G, et al.
J Liq Biopsy
. 2025 Mar;
2:100128.
PMID: 40028489
Background: Lung cancer is the leading cause of cancer death worldwide. Over the last decade, molecular testing of a growing number of predictive biomarkers has become mandatory in the management...
4.
Buono M, Russo G, Nardone V, Della Corte C, Natale G, Rubini D, et al.
J Liq Biopsy
. 2025 Mar;
5:100153.
PMID: 40027942
This work provides a comprehensive overview of the current landscape of lung cancer, emphasizing the global significance of the disease and the challenges associated with its diagnosis and treatment. The...
5.
Scimone C, Pepe F, Russo G, Palumbo L, Ball G, Morel P, et al.
J Liq Biopsy
. 2025 Mar;
3:100133.
PMID: 40026570
Introduction: p.G12C hot spot mutations has rapidly modified diagnostic algorithm for lung cancer patients electing Non-Small Cell Lung Cancer (NSCLC) patients to target treatment. As regards, patients that harbor this...
6.
Montalti R, Pepe F, Cassese G, Russo G, Malapelle U, Carlomagno C, et al.
Eur J Surg Oncol
. 2025 Feb;
51(6):109706.
PMID: 40009912
Introduction: Liver resection represents the cornerstone treatment for Colo-Rectal Liver Metastases (CRLM), but it is still followed by a high recurrence rate. The identification of a valid and reproducible predictor...
7.
Acanfora G, Iaccarino A, Cerbelli B, Di Cristofano C, Bellevicine C, Barberis M, et al.
Cancer Cytopathol
. 2025 Feb;
133(3):e70003.
PMID: 39992702
Introduction: The aim of this project is to assess interobserver agreement for programmed death-ligand 1 (PD-L1) scoring on of non-small cell lung cancer (NSCLC) on cytological specimens in a large-scale...
8.
Zannoni G, Angelico G, Spadola S, Bragantini E, Troncone G, Fraggetta F, et al.
Gynecol Oncol
. 2025 Feb;
194:1-10.
PMID: 39919553
Ovarian carcinoma, the second most common gynecological cancer in Western countries, is frequently diagnosed at advanced stages, necessitating complex treatment strategies. While cytoreductive surgery remains the standard for improving survival,...
9.
Gristina V, Bazan V, Barraco N, Taverna S, Manno M, Raccosta S, et al.
Mol Oncol
. 2025 Jan;
PMID: 39780749
Extracellular vesicle (EV) monitoring can complement clinical assessment of cancer response. In this study, patients with advanced non-small cell lung cancer (NSCLC) undergoing osimertinib, alectinib, pembrolizumab or platinum-based chemotherapy ± ...
10.
Carillo A, Sorice I, Salatiello M, Di Crescenzo R, Pisapia P, Orabona G, et al.
Pathologica
. 2025 Jan;
116(6):358-367.
PMID: 39748721
Background: Although the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) has improved the diagnosis and management of salivary gland lesions, determining the risk of malignancy (ROM) for AUS and...